Evaluation of pathogen P21 protein as a potential modulator of the protective immunity induced by Trypanosoma cruzi attenuated parasites

Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection

(2018) Minerva Arce-Fonseca et al.   Journal of Immunology Research

Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi

(2017) Ivan Bontempi et al.   Immunotherapy

Development and assessment of a new cage-like particle adjuvant

(2017) Daiana Bertona et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection

(2017) Mariana Gatto et al.   JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES

Mechanistic Insights into the Anti-angiogenic Activity of Trypanosoma cruzi Protein 21 and its Potential Impact on the Onset of Chagasic Cardiomyopathy

(2017) Samuel Cota Teixeira et al.   Scientific Reports

A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection

(2016) Marina N. Matos et al.   VACCINE

A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease

(2016) Meagan A. Barry et al.   Human Vaccines & Immunotherapeutics

Trypanosoma cruziInfection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1–Dependent Mechanisms

(2015) Carolina V. Poncini et al.   JOURNAL OF IMMUNOLOGY

Analytical Validation of Quantitative Real-Time PCR Methods for Quantification of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients

(2015) Juan Carlos Ramírez et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy

(2015) Thaise Lara Teixeira et al.   Scientific Reports

A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi

(2015) Shivali Gupta et al.   PLoS Pathogens

Immunity and immune modulation inTrypanosoma cruziinfection

(2015) Fabíola Cardillo et al.   Pathogens and Disease

Gene-deleted live-attenuatedTrypanosoma cruziparasites as vaccines to protect against Chagas disease

(2014) Fernando J Sánchez-Valdéz et al.   Expert Review of Vaccines

Adenovirus Vector-Induced CD8+ T Effector Memory Cell Differentiation and Recirculation, But Not Proliferation, Are Important for Protective Immunity Against Experimental Trypanosoma cruzi Infection

(2014) José Ronnie Vasconcelos et al.   HUMAN GENE THERAPY

A successful strategy for the recovering of active P21, an insoluble recombinant protein of Trypanosoma cruzi

(2014) Marlus Alves dos Santos et al.   Scientific Reports

Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects

(2012) Eric Dumonteil et al.   Expert Review of Vaccines

A Recombinant Protein Based on Trypanosoma cruzi P21 Enhances Phagocytosis

(2012) Adele A. Rodrigues et al.   PLoS One

Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8+T cell mediated immunity against Trypanosoma cruzi

(2012) Shivali Gupta et al.   VACCINE

Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool

(2012) Cecilia Pérez Brandan et al.   Bioengineered

IL-10 Limits Parasite Burden and Protects against Fatal Myocarditis in a Mouse Model of Trypanosoma cruzi Infection

(2011) E. Roffe et al.   JOURNAL OF IMMUNOLOGY

Knockout of the dhfr-ts Gene in Trypanosoma cruzi Generates Attenuated Parasites Able to Confer Protection against a Virulent Challenge

(2011) Cecilia Perez Brandan et al.   PLoS Neglected Tropical Diseases

Characterization of a 21kDa protein from Trypanosoma cruzi associated with mammalian cell invasion

(2009) Claudio V. da Silva et al.   MICROBES AND INFECTION